Skip to content

Evaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact Lenses

Clinical Evaluation of the Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution Compared to a Marketed Multi-Purpose Solution for Care of Soft Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00382681
Enrollment
252
Registered
2006-09-29
Start date
2004-07-31
Completion date
2004-11-30
Last updated
2012-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Care

Keywords

Contact Lens Care

Brief summary

The objective of the study was to clinically evaluate the safety and effectiveness of a new multi-purpose disinfecting solution for soft contact lenses.

Interventions

DEVICEFID 107027 Multi-Purpose Disinfecting Solution

Investigational, multi-purpose disinfecting solution intended for use in cleaning, rinsing, conditioning, disinfecting, and storing soft contact lenses.

DEVICEReNu MultiPlus Multi-Purpose Solution No Rub Formula

Commercially marketed product indicated for cleaning, rinsing, disinfecting, and storing soft contact lenses.

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Successful daily wear of FDA Group I or IV lenses on a two-week or longer replacement schedule for at least one month. * Use of a multi-purpose solution only as the pre-study care regimen for at least one month (rewetting drops use is also acceptable). * Successful lens wear for at least 8 hours per day. * Vision correctable to 20/30. * Normal eyes - no current ocular abnormalities that prevent successful contact lens wear. * No corneal surgery within the past 12 months. * No systemic disease that affects that eye or that could be worsened by the use of contact lenses or solutions. * No over-the-counter or prescription ocular medication. * No enrollment in another clinical study within 30 days prior to enrollment.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Lens Cleanliness - Residual lens lysozyme (HPLC) at Day 90 on Group IV lensesDay 90

Secondary

MeasureTime frame
Average Lens Wearing TimeDay 90

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026